Human Anti-MS4A1 Recombinant Antibody (clone Rmut8)
The monoclonal antibody Rmut8 is derived from rituximab comprising H57DE/H102YK/L93NR mutations. Rmut8 shows strongly enhanced ADCC activity than Rituximab. The tumor killing effect of Rmut8 is significantly higher than Rituximab.
| Supplier | Creative Biolabs |
|---|---|
| Product # | HPAB-0683-CN |
| Pricing | Inquiry |
| Host | Human |
| Target | MS4A1 |
| Species Reactivity | Human |
| Type | Chimeric (mouse/human) IgG |
| Applications | ELISA, FC |
| Storage | Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |